Search
Filter Results
Displaying 171–180 of 1069 results for “good fc coin websites Visit Buyfc26coins.com for latest FC 26 coins news..4sCp”
-
Jul 27, 2020
jCyte Reports Promising Results for Phase 2b Clinical Trial of its Cellular Therapy for RP
Research NewsThe emerging therapy is designed to work independent of the mutated gene causing vision loss
-
Mar 11, 2026
How to Know if a Therapist is Right For You
WellnessWhen you consider starting a therapeutic relationship with a new provider, pay attention to whether you are able to develop a sense of trust, safety, and collaboration with your therapist first and foremost.
-
Apr 1, 2022
Drug for Alcohol Abuse May Restore Vision for People with Retinal Diseases
Research NewsThe drug holds promise for enabling retinal-disease patients to get more vision from remaining photoreceptors
-
For Media
-
-
Mar 17, 2016
Two New Videos Highlight the Foundation's Vital Role in Retinal Research
Research NewsDr. Shannon Boye and her Foundation-funded research is the subject of not just one but two new Foundation videos.
-
Apr 27, 2023
Foundation NewsThe May 11th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
Dec 21, 2016
FFB-CRI Leads Effort to Identify Outcome Measures for Therapies in Clinical Trials
Research NewsImproved outcome measures will make clinical trials for degenerative retinal diseases — including age-related macular degeneration (AMD), the world’s leading cause of blindness in seniors, and inherited retinal conditions such as RP and Stargardt disease — less expensive to conduct and able to deliver more precise results.
-
Sep 27, 2017
The Foundation's Investments Are Filling the Pipeline for Vision-Saving Therapies
Research NewsIn addition to funding promising biotech start-ups, the Foundation Fighting Blindness has played a critical role in developing research talent.
-
Aug 22, 2018
Ophthotech is Advancing an Impressive Portfolio of Cutting-Edge Therapies for Retinal Diseases
Research NewsThe company is taking on a multi-track strategy that includes retinal gene-therapy development, including delivery of over-sized genes and design of a two-step process of gene knockdown and replacement for autosomal dominant conditions.